NM_001382273.1:c.1029C>T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP6_Very_StrongBP7BS2
The NM_001382273.1(TNK2):c.1029C>T(p.Ile343Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00843 in 1,612,996 control chromosomes in the GnomAD database, including 79 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
 Genomes: 𝑓 0.0087   (  16   hom.,  cov: 32) 
 Exomes 𝑓:  0.0084   (  63   hom.  ) 
Consequence
 TNK2
NM_001382273.1 synonymous
NM_001382273.1 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -0.813  
Publications
3 publications found 
Genes affected
 TNK2  (HGNC:19297):  (tyrosine kinase non receptor 2) This gene encodes a tyrosine kinase that binds Cdc42Hs in its GTP-bound form and inhibits both the intrinsic and GTPase-activating protein (GAP)-stimulated GTPase activity of Cdc42Hs. This binding is mediated by a unique sequence of 47 amino acids C-terminal to an SH3 domain. The protein may be involved in a regulatory mechanism that sustains the GTP-bound active form of Cdc42Hs and which is directly linked to a tyrosine phosphorylation signal transduction pathway. Several alternatively spliced transcript variants have been identified from this gene, but the full-length nature of only two transcript variants has been determined. [provided by RefSeq, Jul 2008] 
TNK2 Gene-Disease associations (from GenCC):
- infantile-onset mesial temporal lobe epilepsy with severe cognitive regressionInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -13 ACMG points.
BP6
Variant 3-195878578-G-A is Benign according to our data. Variant chr3-195878578-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 259871.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BP7
Synonymous conserved (PhyloP=-0.813 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 16 AR gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| TNK2 | NM_001382273.1  | c.1029C>T | p.Ile343Ile | synonymous_variant | Exon 8 of 16 | ENST00000672887.2 | NP_001369202.1 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| TNK2 | ENST00000672887.2  | c.1029C>T | p.Ile343Ile | synonymous_variant | Exon 8 of 16 | NM_001382273.1 | ENSP00000499899.1 | 
Frequencies
GnomAD3 genomes   AF:  0.00873  AC: 1328AN: 152094Hom.:  16  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
1328
AN: 
152094
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.00920  AC: 2269AN: 246678 AF XY:  0.00927   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
2269
AN: 
246678
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.00839  AC: 12263AN: 1460784Hom.:  63  Cov.: 32 AF XY:  0.00835  AC XY: 6064AN XY: 726648 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
12263
AN: 
1460784
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
6064
AN XY: 
726648
show subpopulations 
African (AFR) 
 AF: 
AC: 
48
AN: 
33470
American (AMR) 
 AF: 
AC: 
326
AN: 
44720
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
241
AN: 
26134
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39696
South Asian (SAS) 
 AF: 
AC: 
141
AN: 
86232
European-Finnish (FIN) 
 AF: 
AC: 
1388
AN: 
52792
Middle Eastern (MID) 
 AF: 
AC: 
35
AN: 
5522
European-Non Finnish (NFE) 
 AF: 
AC: 
9629
AN: 
1111876
Other (OTH) 
 AF: 
AC: 
455
AN: 
60342
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.483 
Heterozygous variant carriers
 0 
 718 
 1436 
 2154 
 2872 
 3590 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 332 
 664 
 996 
 1328 
 1660 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.00872  AC: 1328AN: 152212Hom.:  16  Cov.: 32 AF XY:  0.00953  AC XY: 709AN XY: 74426 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
1328
AN: 
152212
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
709
AN XY: 
74426
show subpopulations 
African (AFR) 
 AF: 
AC: 
77
AN: 
41542
American (AMR) 
 AF: 
AC: 
129
AN: 
15282
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
30
AN: 
3468
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5154
South Asian (SAS) 
 AF: 
AC: 
7
AN: 
4828
European-Finnish (FIN) 
 AF: 
AC: 
281
AN: 
10608
Middle Eastern (MID) 
 AF: 
AC: 
4
AN: 
292
European-Non Finnish (NFE) 
 AF: 
AC: 
710
AN: 
68014
Other (OTH) 
 AF: 
AC: 
18
AN: 
2114
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.496 
Heterozygous variant carriers
 0 
 69 
 138 
 207 
 276 
 345 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 20 
 40 
 60 
 80 
 100 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
6
AN: 
3478
EpiCase 
 AF: 
EpiControl 
 AF: 
ClinVar
Significance: Benign/Likely benign 
Submissions summary: Benign:3 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:2 
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified    Benign:1 
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.